🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this trial is to compare an individually optimized dose of...
Status
Completed
Location
IMEREM GmbH
Start Date
TBD
Trial ID
NCT00367822
Treatments Being Tested
Ropinirole Hydrochloride (ROP) was granted approval for the treatment of Pa...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-06
Trial ID
NCT00485069
Treatments Being Tested
The purpose of this proposal is to determine if switching PD patients treat...
Status
Completed
Location
Medical University of Ohio
Start Date
2007-01
Trial ID
NCT00465452
Treatments Being Tested
The purpose of this study is to assess the safety and feasibility of switch...
Status
Completed
Location
505
Start Date
2012-09
Trial ID
NCT01711866
Treatments Being Tested
The primary objective is to demonstrate safety and tolerability of switchin...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2014-08
Trial ID
NCT01976871
Treatments Being Tested
The purpose of this clinical trial is to investigate the effects of the non...
Status
Completed
Location
Multiple Locations
Start Date
2010-01
Trial ID
NCT01007864
Treatments Being Tested
The purpose of this study is to determine the equipotent dose of ropinirole...
Status
Completed
Location
Medical College of Georgia
Start Date
2006-05
Trial ID
NCT00344994
Treatments Being Tested
The purpose of this research study is to see if subjects with Parkinson's d...
Status
Unknown
Location
Colorado Neurology, P.C.
Start Date
2005-11
Trial ID
NCT00260793
Treatments Being Tested
This study will evaluate the effectiveness of naltrexone in reducing ICD sy...
Status
Completed
Location
University of Pennsylvania
Start Date
2009-11
Trial ID
NCT01052831
Treatments Being Tested
This research aims to compare the efficacy of these two interventions, ther...
Status
Completed
Location
Lahore General Hospital, Lahore
Start Date
2022-01-02
Trial ID
NCT06468371
Treatments Being Tested